Takanashi Ken
CIK 0001657768
Director10% Owner
Filings
7
Latest Mar 26, 2026
Issuers covered
2
Showing
7 of 7
Page 1
Track record
1 of 2 open-market trades scored (50% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +7.5% | +7.5% | +7.5% | +7.5% |
| 90 days | 1 | 100% | +6.0% | +6.0% | +6.0% | +6.0% |
| 180 days | 1 | 0% | -51.9% | -51.9% | -51.9% | -51.9% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Takanashi Ken has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | 5 | Mar 26, 2026 |
| STSA | Satsuma Pharmaceuticals, Inc. | 2 | Jun 8, 2023 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|